KIDSNasdaqSurgical & Medical Instruments & ApparatusUS GAAP · USD

OrthoPediatrics Corp

OrthoPediatrics Corp. is a U.S.-based medical device company focused on orthopedic products designed specifically for children. Its portfolio includes implants, surgical instruments, specialized braces, and orthotic and prosthetic clinic services used by pediatric orthopedic surgeons, orthotists, and related care providers in the United States and international markets.

Revenue236m USD
+15.4 %y/y
Operating profit (EBIT)-39.2m USD
−12.1 %y/y
EBIT margin-16.6%
+0.5 ppy/y
Net income-39.6m USD
−4.8 %y/y
Free cash flow-16.0m USD
+61.4 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

-1000100200300m USD2020: 19 m USD2020: EBIT -13 m USD20202021: 25 m USD2021: EBIT -18 m USD20212022: 122 m USD2022: EBIT -25 m USD20222023: 149 m USD2023: EBIT -27 m USD20232024: 205 m USD2024: EBIT -35 m USD20242025: 236 m USD2025: EBIT -39 m USD2025236-39
RevenueOperating profit (EBIT)

Business

Share of revenue
Surgical implants and instruments55 %

Anatomically appropriate implant systems and the instrument sets used in pediatric orthopedic procedures.

Specialized bracing25 %

Custom and off-the-shelf pediatric braces, including scoliosis and growth-modulation products.

Orthotic and prosthetic clinic services15 %

Clinic-based fitting and treatment services for children needing non-surgical orthopedic care.

Other pediatric orthopedic products5 %

Adjunct systems such as sports medicine, spine, and specialty procedure-specific products.

Products

Reported · share of revenue
70.4%27.9%FY2025100 %
  • Traumaand Deformity70.4 %
  • Spine27.9 %
  • Sports Medicine and Other1.7 %

Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.

Customers

The company sells primarily to pediatric orthopedic surgeons and the hospitals or medical facilities where they perform procedures. It also serves orthotists, physical therapists, and, in some cases, end customers directly through bracing and clinic-based care. Internationally, products are sold through distributors and sales agencies, while in selected markets the company uses direct sales to hospitals.

Pediatric orthopedic surgeons

Buy implant systems, instruments, and procedure-specific tools for trauma, deformity, scoliosis, and sports medicine cases.

Hospitals and medical facilities

Host consigned implant and instrument sets and purchase products when used or shipped, depending on market structure.

Orthotists and physical therapists

Buy or fit bracing products and support non-surgical pediatric orthopedic treatment.

Patients and families

Receive custom braces and clinic services, especially through the company's O&P clinics.

International distributors and agencies

Purchase or facilitate sales of implants and braces in overseas markets and manage local hospital relationships.

Strategy

The company is expanding its installed base of consigned implant and instrument sets to improve hospital coverage and increase procedure access. It is also broadening its pediatric orthopedic portfolio through research and development, product line extensions, and selective acquisitions, while extending its clinic network and international sales infrastructure.

Expand consigned inventory coverageShort term

Pediatric orthopedic procedures often require full implant sets on site before revenue can be realized.

Broaden product portfolioMedium term

A wider offering improves surgeon adoption and addresses more pediatric orthopedic conditions.

Strengthen international distributionMedium term

Local sales and warehouse presence improves service levels and market access outside the U.S.

Expand O&P clinic networkMedium term

Clinic services deepen the company’s role in non-surgical pediatric orthopedic care.

Geography

Q1/2026

OrthoPediatrics is headquartered in Warsaw, Indiana and sells in the United States and more than 75 countries internationally. The company has direct sales programs in selected markets such as the UK, Ireland, Australia, New Zealand, Canada, Belgium, the Netherlands, Italy, Germany, Switzerland, and Austria, and it operates warehouses and local entities in Europe and Australia to support distribution. Its manufacturing footprint includes in-house bracing production in Iowa, the UK, and Boston, while most implants and instruments are produced in the United States through contract manufacturing.

United States76 %
Other countries (US filing)24 %

Share of the revenue the company reports by geography.

Risks

The business depends on elective pediatric procedures, surgeon adoption, and hospital access, so disruptions in procedure volumes or reimbursement can affect demand. International operations add exposure to distributor credit risk, product returns, trade compliance, and foreign market execution, while the company’s inventory-heavy model requires careful management of consigned sets and working capital.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Surgeon adoption and training risk1Regulatory and reimbursement risk2Inventory and consignment risk4International credit and return risk5
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Surgeon adoption and training riskImpact: HighLikelihood: Medium

    Products require surgeon familiarity and proper technique; weak adoption can limit sales growth.

    Exposure: All implant and instrument systems

  2. Regulatory and reimbursement riskImpact: HighLikelihood: Medium

    Medicaid and other payer changes can affect reimbursement for pediatric orthopedic procedures.

    Exposure: U.S. clinic and procedure reimbursement

  3. Elective surgery volume disruptionImpact: High

    Most products are used in elective pediatric procedures, so hospital postponements reduce utilization.

    ExposureTraumaDeformityScoliosis procedures
  4. Inventory and consignment riskImpact: MediumLikelihood: Medium

    The model requires substantial upfront investment in hospital consignment sets and inventory.

    Exposure: Implants and instruments held on consignment

  5. International credit and return riskImpact: MediumLikelihood: Low

    Overseas customers may return products and some distributors are thinly capitalized.

    Exposure: Distributor-led international sales

Accounting

Judgemental items
Revenue recognition by channel

Different recognition points for implants, braces, and clinics affect quarter-to-quarter comparability.

Impact: Implants on consignment, shipped braces, and fitted clinic services

Estimated contractual allowances and concessions

Clinic revenue is recorded net of expected reimbursement and later claim adjudication adjustments.

Impact: Reported revenue and accounts receivable

Consigned inventory accounting

Inventory remains on the balance sheet until used in surgery, affecting working capital and cost timing.

Impact: Inventory, cost of revenue, and gross margin

Seasonality

Procedure volumes are higher in summer and holiday periods, affecting quarterly revenue patterns.

Impact: Revenue comparability across quarters

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026

OrthoPediatrics Corp (KIDS) Revenue, Earnings & Financials 2025 – Clarifo